These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37836471)

  • 21. [Effect of Danlou Tablets on alleviating hepatic adipogenesis, inflammatory response, and insulin resistance in db/db mice].
    Pang YF; Huang M; Li L; Zhao X; Zhang HX; Li YH
    Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3320-3327. PubMed ID: 35851126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
    Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
    J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptome analysis reveals the molecular mechanism of hepatic fat metabolism disorder caused by Muscovy duck reovirus infection.
    Wang Q; Liu M; Xu L; Wu Y; Huang Y
    Avian Pathol; 2018 Apr; 47(2):127-139. PubMed ID: 28911249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
    Kohjima M; Enjoji M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Takayanagi R; Nakamuta M
    Int J Mol Med; 2007 Sep; 20(3):351-8. PubMed ID: 17671740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism.
    Dai W; Xiang W; Han L; Yuan Z; Wang R; Ma Y; Yang Y; Cai S; Xu Y; Mo S; Li Q; Cai G
    Cancer Commun (Lond); 2022 Sep; 42(9):848-867. PubMed ID: 35904817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.
    López-Oliva ME; Garcimartin A; Muñoz-Martínez E
    Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPARα (Peroxisome Proliferator-activated Receptor α) Activation Reduces Hepatic CEACAM1 Protein Expression to Regulate Fatty Acid Oxidation during Fasting-refeeding Transition.
    Ramakrishnan SK; Khuder SS; Al-Share QY; Russo L; Abdallah SL; Patel PR; Heinrich G; Muturi HT; Mopidevi BR; Oyarce AM; Shah YM; Sanchez ER; Najjar SM
    J Biol Chem; 2016 Apr; 291(15):8121-9. PubMed ID: 26846848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P633H, a novel dual agonist at peroxisome proliferator-activated receptors alpha and gamma, with different anti-diabetic effects in db/db and KK-Ay mice.
    Chen W; Zhou XB; Liu HY; Xu C; Wang LL; Li S
    Br J Pharmacol; 2009 Jul; 157(5):724-35. PubMed ID: 19422369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of hepatic transcriptome demonstrates altered lipid metabolism following Lactobacillus johnsonii BS15 prevention in chickens with subclinical necrotic enteritis.
    Qing X; Zeng D; Wang H; Ni X; Lai J; Liu L; Khalique A; Pan K; Jing B
    Lipids Health Dis; 2018 Apr; 17(1):93. PubMed ID: 29678171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
    Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
    Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice.
    Zhao J; He K; Du H; Wei G; Wen Y; Wang J; Zhou X; Wang J
    PeerJ; 2022; 10():e13932. PubMed ID: 36157062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease.
    Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y
    Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic PGC-1beta overexpression induces combined hyperlipidemia and modulates the response to PPARalpha activation.
    Lelliott CJ; Ljungberg A; Ahnmark A; William-Olsson L; Ekroos K; Elmgren A; Arnerup G; Shoulders CC; Oscarsson J; Lindén D
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2707-13. PubMed ID: 17932310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Creosote Bush-Derived NDGA on Expression of Genes Involved in Lipid Metabolism in Liver of High-Fructose Fed Rats: Relevance to NDGA Amelioration of Hypertriglyceridemia and Hepatic Steatosis.
    Zhang H; Li Y; Hu J; Shen WJ; Singh M; Hou X; Bittner A; Bittner S; Cortez Y; Tabassum J; Kraemer FB; Azhar S
    PLoS One; 2015; 10(9):e0138203. PubMed ID: 26394137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice.
    Oosterveer MH; Grefhorst A; van Dijk TH; Havinga R; Staels B; Kuipers F; Groen AK; Reijngoud DJ
    J Biol Chem; 2009 Dec; 284(49):34036-44. PubMed ID: 19801551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
    Goetzman ES; Tian L; Wood PA
    Mol Genet Metab; 2005 Jan; 84(1):39-47. PubMed ID: 15639194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deletion of fatty acid transport protein 2 (FATP2) in the mouse liver changes the metabolic landscape by increasing the expression of PPARα-regulated genes.
    Perez VM; Gabell J; Behrens M; Wase N; DiRusso CC; Black PN
    J Biol Chem; 2020 Apr; 295(17):5737-5750. PubMed ID: 32188695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling.
    Yoshikawa T; Ide T; Shimano H; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Yatoh S; Kitamine T; Okazaki H; Tamura Y; Sekiya M; Takahashi A; Hasty AH; Sato R; Sone H; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1240-54. PubMed ID: 12730331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.